MENU
HTEC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

HTEC stock forecast, quote, news & analysis

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
HTEC
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for HTEC with price predictions
Oct 26, 2026

HTEC's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for HTEC turned positive on October 21, 2026. Looking at past instances where HTEC's MACD turned positive, the stock continued to rise in 50 of 55 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on HTEC as a result. In 76 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

HTEC moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where HTEC advanced for three days, in 262 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

HTEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 206 of 246 cases where HTEC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.

Bearish Trend Analysis

The 10-day RSI Indicator for HTEC moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 30 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HTEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH).

Industry description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.

Market Cap

The average market capitalization across the ROBO Global Healthcare Technology and Innovation ETF (HTEC) ETF is 34.31B. The market cap for tickers in the group ranges from 941.05M to 249.14B. TMO holds the highest valuation in this group at 249.14B. The lowest valued company is IART at 941.05M.

High and low price notable news

The average weekly price growth across all stocks in the ROBO Global Healthcare Technology and Innovation ETF (HTEC) ETF was 4%. For the same ETF, the average monthly price growth was 0%, and the average quarterly price growth was 38%. CRL experienced the highest price growth at 19%, while MRNA experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the ROBO Global Healthcare Technology and Innovation ETF (HTEC) ETF was -4%. For the same stocks of the ETF, the average monthly volume growth was -12% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 51
Price Growth Rating: 39
SMR Rating: 72
Profit Risk Rating: 82
Seasonality Score: 32 (-100 ... +100)
HTEC's MACD Histogram crosses above signal line